Will Abbott Stock Rise After Its Q4 Results? | Your Source for the Hottest Growth Stock Research and News

For perspective, Abbott expects total Covid-19 related sales of $500 million in Q4, compared to $2.3 billion in the prior-year quarter.

January Recap Showing Conservatively, Over 400% in Bookable Gains and Over 1,720% in Bookable Gains Peak to Trough for our Members February 1, 2023

Hello everyone and welcome to all our new members, As we mentioned in late December the changes and improvements we are making will benefit our entire group and should only improve from here. It has been an amazing start to the year as we look at the January re-cap. All six of our January

This company could be on the cusp of something monumental as their lead product is a disruptive “world’s first” in this med-tech space. January 31, 2023

Hello everyone and welcome to all our new members, This company could be on the cusp of something monumental as their lead product is a disruptive “world’s first” in this med-tech space. Sharps Technology, Inc. (NASDAQ: STSS) The company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate

Three Stocks That Have a Strong Possibility of Becoming the Next Big Short Squeeze January 31, 2023

It is no surprise that the best trades of late have been stocks with an unjustifiably large amount of short interest. Sometimes you find one of these and scratch your head, thinking “why such a large short position in this company?” Well, we have been watching three and one has less than 1M shares in

Like to share?